# Corcept Therapeutics Incorporated (CORT) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | $45M |
| 2024 | $137M |
| 2023 | $107M |
| 2022 | $113M |
| 2021 | $124M |
| 2020 | $128M |
| 2019 | $112M |
| 2018 | $89M |
| 2017 | $53M |
| 2016 | $10M |
| 2009 | -$20M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$50M |
| 2025-09-30 | $10M |
| 2025-06-30 | $27M |
| 2025-03-31 | $3M |
| 2024-09-30 | $47M |
| 2024-06-30 | $36M |
| 2024-03-31 | $30M |
| 2023-09-30 | $31M |
| 2023-06-30 | $30M |
| 2023-03-31 | $15M |
| 2022-09-30 | $32M |
| 2022-06-30 | $31M |
| 2022-03-31 | $27M |
| 2021-09-30 | $36M |
| 2021-06-30 | $32M |
| 2021-03-31 | $20M |
| 2020-09-30 | $25M |
| 2020-06-30 | $35M |
| 2020-03-31 | $38M |
| 2019-09-30 | $33M |
| 2019-06-30 | $25M |
| 2019-03-31 | $19M |
| 2018-09-30 | $23M |
| 2018-06-30 | $21M |

Source: [CompaniesByCap](https://companiesbycap.com/company/CORT/operating-income)